Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marylyn M Addo

Showing results (111-120 of 183) with videos related to

Pageof 19
Sort By:
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 1, 2022
Evidence of surface contamination in hospital rooms occupied by patients infected with monkeypox, Germany, June 2022Dominik Nörz, Susanne Pfefferle, Thomas T Brehm, et al.
Leukemia|December 23, 2021
SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemiaSibylle C Mellinghoff, Sandra Robrecht, Leonie Mayer, et al.
Frontiers in Immunology|January 3, 2025
MVA-based SARS-CoV-2 vaccine candidates encoding different spike protein conformations induce distinct early transcriptional responses which may impact subsequent adaptive immunityIlka Grewe, Monika Friedrich, Marie-Louise Dieck, et al.
European Journal of Immunology|April 13, 2022
Natural killer cell-mediated ADCC in SARS-CoV-2-infected individuals and vaccine recipientsKerri Hagemann, Kristoffer Riecken, Johannes M Jung, et al.
Journal of Virology|April 14, 2004
Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptidesDaniel E Kaufmann, Paul M Bailey, John Sidney, et al.
Blood|April 3, 2004
HIV-1-specific cytotoxicity is preferentially mediated by a subset of CD8(+) T cells producing both interferon-gamma and tumor necrosis factor-alphaMathias Lichterfeld, Xu G Yu, Michael T Waring, et al.
Journal of Medical Virology|September 30, 2022
Tecovirimat therapy for severe monkeypox infection: Longitudinal assessment of viral titers and clinical response pattern-A first case-series experienceLennart Hermanussen, Ilka Grewe, Hui Ting Tang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2020
Sustained Response After Remdesivir and Convalescent Plasma Therapy in a B-Cell-Depleted Patient With Protracted Coronavirus Disease 2019 (COVID-19)Jakob Malsy, Luzia Veletzky, Janna Heide, et al.
The Journal of Experimental Medicine|September 24, 2004
Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cellsMathias Lichterfeld, Daniel E Kaufmann, Xu G Yu, et al.
Journal of Hepatology|March 20, 2018
HEV-positive blood donations represent a relevant infection risk for immunosuppressed recipientsDirk Westhölter, Jens Hiller, Ulrike Denzer, et al.
Pageof 19

Showing results (111-120 of 183) with videos related to

Sort By:
Pageof 19
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 1, 2022
Evidence of surface contamination in hospital rooms occupied by patients infected with monkeypox, Germany, June 2022Dominik Nörz, Susanne Pfefferle, Thomas T Brehm, et al.
Leukemia|December 23, 2021
SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemiaSibylle C Mellinghoff, Sandra Robrecht, Leonie Mayer, et al.
Frontiers in Immunology|January 3, 2025
MVA-based SARS-CoV-2 vaccine candidates encoding different spike protein conformations induce distinct early transcriptional responses which may impact subsequent adaptive immunityIlka Grewe, Monika Friedrich, Marie-Louise Dieck, et al.
European Journal of Immunology|April 13, 2022
Natural killer cell-mediated ADCC in SARS-CoV-2-infected individuals and vaccine recipientsKerri Hagemann, Kristoffer Riecken, Johannes M Jung, et al.
Journal of Virology|April 14, 2004
Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptidesDaniel E Kaufmann, Paul M Bailey, John Sidney, et al.
Blood|April 3, 2004
HIV-1-specific cytotoxicity is preferentially mediated by a subset of CD8(+) T cells producing both interferon-gamma and tumor necrosis factor-alphaMathias Lichterfeld, Xu G Yu, Michael T Waring, et al.
Journal of Medical Virology|September 30, 2022
Tecovirimat therapy for severe monkeypox infection: Longitudinal assessment of viral titers and clinical response pattern-A first case-series experienceLennart Hermanussen, Ilka Grewe, Hui Ting Tang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2020
Sustained Response After Remdesivir and Convalescent Plasma Therapy in a B-Cell-Depleted Patient With Protracted Coronavirus Disease 2019 (COVID-19)Jakob Malsy, Luzia Veletzky, Janna Heide, et al.
The Journal of Experimental Medicine|September 24, 2004
Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cellsMathias Lichterfeld, Daniel E Kaufmann, Xu G Yu, et al.
Journal of Hepatology|March 20, 2018
HEV-positive blood donations represent a relevant infection risk for immunosuppressed recipientsDirk Westhölter, Jens Hiller, Ulrike Denzer, et al.
Pageof 19